Detecting metastasis of lymph nodes and predicting aggressiveness in patients with breast carcinomas

Journal of Ultrasound in Medicine

Volumn 29, Issue 3, 2010, Pages 343-352

  Ouyang, Qiufang ^a   Chen, Liwu ^a   Zhao, Hongjia ^a   Xu, Rong ^a   Lin, Qingping ^a  

^a Hospital of Fujian Traditional Chinese Medicine   (China)

Author keywords

Breast neoplasm; Contrast enhanced ultrasonography; Human epidermal growth factor receptor 2; Lymph node metastasis; Reactive hyperplasia lymph node

Indexed keywords

BODY FLUIDS; DISEASES; PATHOLOGY; TUMORS;

BREAST NEOPLASM; CONTRAST-ENHANCED ULTRASONOGRAPHY; HUMAN EPIDERMAL GROWTH FACTOR; LYMPH NODE; LYMPH NODE METASTASIS;

DIAGNOSIS;

CONTRAST AGENT BR1; CONTRAST MEDIUM; DIAGNOSTIC AGENT; PHOSPHOLIPID; SULFUR HEXAFLUORIDE;

ARTICLE; BREAST TUMOR; CARCINOMA; ECHOGRAPHY; ECHOMAMMOGRAPHY; FEMALE; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; METASTASIS; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

BREAST NEOPLASMS; CARCINOMA; CONTRAST MEDIA; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; PHOSPHOLIPIDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SULFUR HEXAFLUORIDE; ULTRASONOGRAPHY, MAMMARY;

EID: 77949801006     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2010.29.3.343     Document Type: Article

References (31)

1. Morrow M. Role of axillary dissection in breast cancer management. Ann Surg Oncol 1996; 3:233-234.
2. Kinne DW. Axillary clearance in operable breast cancer: still a necessity? Recent results. Cancer Res 1998; 152:161-169.
3. Zdemir A, Kiliç K, Ozdemir H, Yücel C, Andaç S, Colak M. Contrast-enhanced power Doppler sonography in breast lesions: effect on differential diagnosis after mammography and gray scale sonography. J Ultrasound Med 2004; 23:183-195.
4. Weskott HP. Emerging roles for contrast-enhanced ultrasound. Clin Hemorheol Microcirc 2008; 40:51-71.
5. Clément O, Luciani A. Imaging the lymphatic system: possibilities and clinical applications. Eur Radiol 2004; 4:1498-1507.
6. Nielsen KR, Grossjohann HS, Hansen CP, Nielsen MB. Use of contrast-enhanced ultrasound imaging to detect the first draining lymph node (FDLN) in a swine model: correlation of imaging findings with the distance from the injection site to the FDLN. J Ultrasound Med 2008; 27:1203-1209.
7. Goldberg BB, Merton DA, Liu JB, Murphy G, Forsberg F. Contrast-enhanced sonographic imaging of lymphatic channels and sentinel lymph nodes. J Ultrasound Med 2005; 24:953-965.
8. Rubaltelli L, Corradin S, Dorigo A, et al. Automated quantitative evaluation of lymph node perfusion on contrastenhanced sonography. AJR Am J Roentgenol 2007; 188:977-983.
9. Rogers CE, Loveday RL, Drew PJ, Greenman J. Molecular prognostic indicators in breast cancer. Eur J Surg Oncol 2002; 28:467-478.
10. Maksimovic S. Prognostic value of HER-2/neu expression in T1 to T3 breast cancer with axillary lymph node metastasis. Breast Cancer Res 2009; 11(suppl 1):P9.
11. Leggett DAC, Miles KA, Kelley BB. Blood-brain barrier and blood volume imaging of cerebral glioma using functional CT: a pictorial review. Australas Radiol 1998; 42:335-340.
12. Dhermain F, Saliou G, Parker F, et al. Microvascular leakage and contrast enhancement as prognostic factors for recurrence in unfavorable low-grade gliomas. J Neurooncol 2010; 97:81-88.
13. Cuenod CA, Fournier L, Balvay D, Guinebretière JM. Tumor angiogenesis: pathophysiology and implications for contrast-enhanced MRI and CT assessment. Abdom Imaging 2006; 31:188-193.
14. Greene FL, Page DL, Fleming ID, et al, AJCC Cancer Staging Manual. 6th ed. New York, NY: Springer-Verlag; 2002.
15. Ying M, Ahuja A, Brook F, Metreweli C. Vascularity and grey-scale sonographic features of normal cervical lymph nodes: variations with nodal size. Clin Radiol 2001; 56:416-419.
16. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86:353-364.
17. Pultrum BB, van der Jagt EJ, van Westreenen HL, et al. Detection of lymph node metastases with ultrasmall super-paramagnetic iron oxide (USPIO)-enhanced magnetic resonance imaging in oesophageal cancer: a feasibility study. Cancer Imaging 2009; 9:19-28.
18. Som PM. Detection of metastasis in cervical lymph nodes: CT and MRI criteria and differential diagnosis. AJR Am J Roentgenol 1992; 158:961-969.
19. Wu CH, Hsu MM, Chang YL, Hsieh FJ. Vascular pathology of malignant cervical lymphadenopathy: qualitative and quantitative assessment with power Doppler ultrasound. Cancer 1998; 83:1189-1196.
20. Santamaría G, Velasco M, Farré X, Vanrell JA, Cardesa A, Fernández PL. Power Doppler sonography of invasive breast carcinoma: does tumor vascularization contribute to prediction of axillary status? Radiology 2005; 234:374-380.
21. Boucher Y, Jain RK. Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. Cancer Res 1992; 52: 5110-5114.
22. Leu AJ, Berk DA, Lymboussaki A, Alitalo K, Jain RK. Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation. Cancer Res 2000; 60: 4324-4327.
23. Griffon-Etienne G, Boucher Y, Brekken C, Suit HD, Jain RK. Taxane-induced apoptosis decompresses blood vessels and lowers interstitial fluid pressure in solid tumors: clinical implications. Cancer Res 1999; 59:3776-3782.
24. Baish JW, Netti PA, Jain RK. Transmural coupling of fluid flow in microcirculatory network and interstitium in tumors. Microvasc Res 1997; 53:128-141.
25. Bachmann IM, Ladstein RG, Straume O, Naumov GN, Akslen LA. Tumor necrosis is associated with increased alphavbeta3 integrin expression and poor prognosis in nodular cutaneous melanomas. BMC Cancer 2008; 8:362.
26. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000; 407:257-259.
27. Richard DE, Berra E, Pouyssegur J. Angiogenesis: how a tumor adapts to hypoxia. Biochem Biophys Res Commun 1999; 266:718-722.
28. Du J, Li FH, Fang H, Xia JG, Zhu CX. Correlation of real-time gray scale contrast-enhanced ultrasonography with microvessel density and vascular endothelial growth factor expression for assessment of angiogenesis in breast lesions. J Ultrasound Med 2008; 27:821-831.
29. Zhao H, Xu R, Ouyang Q, Chen L, Dong B, Huihua Y. Contrast-enhanced ultrasound is helpful in the differentiation of malignant and benign breast lesions [published online ahead of print June 24, 2009]. Eur J Radiol. doi:10.1016/j.ejrad.2009.05.043.
30. Sivridis E, Giatromanolaki A, Koukourakis MI. The vascular network of tumors: what is it not for? J Pathol 2003; 201:173-180.
31. Yang WT, Metreweli C, Lam PK, Chang J. Benign and malignant breast masses and axillary nodes: evaluation with echo-enhanced color power Doppler US. Radiology 2001; 220:795-802.